The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...

In a significant medical breakthrough, the widely used weight loss drug Wegovy has shown remarkable success in treating a severe form of liver disease known as metabolic dysfunction-associated ...

MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which was ... maker of Ozempic and Wegovy, in a press release provided to Fox News Digital.